Search research articles
Contact Us
Filters
Showing results (121-130 of 126) with videos related to
Page
of 13
Sort By:
You have reached the last page of results.
This site can display upto 126 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 4, 2007
Phase I evaluation of a fully human anti-alphav integrin monoclonal antibody (CNTO 95) in patients with advanced solid tumors
Saifee A Mullamitha, Nhuan C Ton, Geoff J M Parker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 17, 2023
Multi-Maintenance Olaparib Therapy in Relapsed, Germline BRCA1/2-Mutant High-Grade Serous Ovarian Cancer (MOLTO): A Phase II Trial
Robert D Morgan, Andrew R Clamp, Daniel J White, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 29, 2009
Quantifying antivascular effects of monoclonal antibodies to vascular endothelial growth factor: insights from imaging
James P B O'Connor, Richard A D Carano, Andrew R Clamp, et al.
Metabolomics : Official Journal of the Metabolomic Society
|
January 20, 2015
Molecular phenotyping of a UK population: defining the human serum metabolome
Warwick B Dunn, Wanchang Lin, David Broadhurst, et al.
Eclinicalmedicine
|
June 24, 2026
Cediranib with weekly paclitaxel or olaparib versus weekly paclitaxel for advanced or recurrent endometrial cancer (COPELIA): a multicentre, open-label, randomised, phase 2 trial in the UK
Robert D Morgan, Catharine Porter, Cong Zhou, et al.
Nature Reviews. Clinical Oncology
|
October 12, 2016
Imaging biomarker roadmap for cancer studies
James P B O'Connor, Eric O Aboagye, Judith E Adams, et al.
Page
of 13
Search research articles
Search
Showing results (121-130 of 126) with videos related to
Sort By:
Page
of 13
You have reached the last page of results.
This site can display upto 126 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 4, 2007
Phase I evaluation of a fully human anti-alphav integrin monoclonal antibody (CNTO 95) in patients with advanced solid tumors
Saifee A Mullamitha, Nhuan C Ton, Geoff J M Parker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 17, 2023
Multi-Maintenance Olaparib Therapy in Relapsed, Germline BRCA1/2-Mutant High-Grade Serous Ovarian Cancer (MOLTO): A Phase II Trial
Robert D Morgan, Andrew R Clamp, Daniel J White, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 29, 2009
Quantifying antivascular effects of monoclonal antibodies to vascular endothelial growth factor: insights from imaging
James P B O'Connor, Richard A D Carano, Andrew R Clamp, et al.
Metabolomics : Official Journal of the Metabolomic Society
|
January 20, 2015
Molecular phenotyping of a UK population: defining the human serum metabolome
Warwick B Dunn, Wanchang Lin, David Broadhurst, et al.
Eclinicalmedicine
|
June 24, 2026
Cediranib with weekly paclitaxel or olaparib versus weekly paclitaxel for advanced or recurrent endometrial cancer (COPELIA): a multicentre, open-label, randomised, phase 2 trial in the UK
Robert D Morgan, Catharine Porter, Cong Zhou, et al.
Nature Reviews. Clinical Oncology
|
October 12, 2016
Imaging biomarker roadmap for cancer studies
James P B O'Connor, Eric O Aboagye, Judith E Adams, et al.
Page
of 13